Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus
Authors
Keywords
-
Journal
Journal of Diabetes
Volume 7, Issue 5, Pages 729-739
Publisher
Wiley
Online
2014-10-18
DOI
10.1111/1753-0407.12232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
- (2014) Nathalie Esser et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Probiotic (VSL#3) and Omega-3 on Lipid Profile, Insulin Sensitivity, Inflammatory Markers, and Gut Colonization in Overweight Adults: A Randomized, Controlled Trial
- (2014) Hemalatha Rajkumar et al. MEDIATORS OF INFLAMMATION
- Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease
- (2014) Longbiao Yao et al. Journal of Immunology Research
- Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
- (2013) Verena Wieser et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study
- (2013) Anne Ofstad et al. Cardiovascular Diabetology
- Type 2 Diabetes Mellitus
- (2013) Thomas Mandrup-Poulsen DERMATOLOGIC CLINICS
- Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes
- (2013) Fadia Mahmoud et al. DISEASE MARKERS
- Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
- (2012) X. Wang et al. DIABETES CARE
- The linkage between inflammation and Type 2 diabetes mellitus
- (2012) Nathália G. Cruz et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Evil Axis of Obesity, Inflammation and Type-2 Diabetes
- (2012) Arghya Das et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production
- (2011) Luc De Vuyst et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?
- (2010) Kees Meijer et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk
- (2010) Melania Manco et al. ENDOCRINE REVIEWS
- Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut Microbiota
- (2009) I. Martinez et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Endotoxin as a missed link among all the metabolic abnormalities in the metabolic syndrome
- (2009) Melania Manco ATHEROSCLEROSIS
- Effect of Acarbose on Postmeal Mononuclear Blood Cell Response in Patients with Early Type 2 Diabetes: The AI(I)DA Study
- (2009) M. Hanefeld et al. HORMONE AND METABOLIC RESEARCH
- The gut microbiota modulates host energy and lipid metabolism in mice
- (2009) Vidya R. Velagapudi et al. JOURNAL OF LIPID RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started